List of Tables
Table 1. Global Cardiac Glycosides Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Cardiac Glycosides Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Cardiac Glycosides Market Competitive Situation by Manufacturers in 2023
Table 4. Global Cardiac Glycosides Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Cardiac Glycosides Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Cardiac Glycosides Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Cardiac Glycosides Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Cardiac Glycosides Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Cardiac Glycosides, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Cardiac Glycosides, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cardiac Glycosides, Product Type & Application
Table 12. Global Key Manufacturers of Cardiac Glycosides, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cardiac Glycosides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiac Glycosides as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cardiac Glycosides Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Cardiac Glycosides Sales by Region (2019-2024) & (K Units)
Table 18. Global Cardiac Glycosides Sales Market Share by Region (2019-2024)
Table 19. Global Cardiac Glycosides Sales by Region (2025-2030) & (K Units)
Table 20. Global Cardiac Glycosides Sales Market Share by Region (2025-2030)
Table 21. Global Cardiac Glycosides Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Cardiac Glycosides Revenue Market Share by Region (2019-2024)
Table 23. Global Cardiac Glycosides Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Cardiac Glycosides Revenue Market Share by Region (2025-2030)
Table 25. North America Cardiac Glycosides Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Cardiac Glycosides Sales by Country (2019-2024) & (K Units)
Table 27. North America Cardiac Glycosides Sales by Country (2025-2030) & (K Units)
Table 28. North America Cardiac Glycosides Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Cardiac Glycosides Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Cardiac Glycosides Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Cardiac Glycosides Sales by Country (2019-2024) & (K Units)
Table 32. Europe Cardiac Glycosides Sales by Country (2025-2030) & (K Units)
Table 33. Europe Cardiac Glycosides Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Cardiac Glycosides Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Cardiac Glycosides Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Cardiac Glycosides Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Cardiac Glycosides Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Cardiac Glycosides Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Cardiac Glycosides Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Cardiac Glycosides Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Cardiac Glycosides Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Cardiac Glycosides Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Cardiac Glycosides Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Cardiac Glycosides Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Cardiac Glycosides Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Cardiac Glycosides Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Cardiac Glycosides Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Cardiac Glycosides Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Cardiac Glycosides Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Cardiac Glycosides Sales (K Units) by Type (2019-2024)
Table 51. Global Cardiac Glycosides Sales (K Units) by Type (2025-2030)
Table 52. Global Cardiac Glycosides Sales Market Share by Type (2019-2024)
Table 53. Global Cardiac Glycosides Sales Market Share by Type (2025-2030)
Table 54. Global Cardiac Glycosides Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Cardiac Glycosides Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Cardiac Glycosides Revenue Market Share by Type (2019-2024)
Table 57. Global Cardiac Glycosides Revenue Market Share by Type (2025-2030)
Table 58. Global Cardiac Glycosides Price (US$/Unit) by Type (2019-2024)
Table 59. Global Cardiac Glycosides Price (US$/Unit) by Type (2025-2030)
Table 60. Global Cardiac Glycosides Sales (K Units) by Application (2019-2024)
Table 61. Global Cardiac Glycosides Sales (K Units) by Application (2025-2030)
Table 62. Global Cardiac Glycosides Sales Market Share by Application (2019-2024)
Table 63. Global Cardiac Glycosides Sales Market Share by Application (2025-2030)
Table 64. Global Cardiac Glycosides Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Cardiac Glycosides Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Cardiac Glycosides Revenue Market Share by Application (2019-2024)
Table 67. Global Cardiac Glycosides Revenue Market Share by Application (2025-2030)
Table 68. Global Cardiac Glycosides Price (US$/Unit) by Application (2019-2024)
Table 69. Global Cardiac Glycosides Price (US$/Unit) by Application (2025-2030)
Table 70. Sanofi Company Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Cardiac Glycosides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Sanofi Cardiac Glycosides Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Chengdu Beite Pharmaceutical Co., Ltd. Company Information
Table 76. Chengdu Beite Pharmaceutical Co., Ltd. Description and Business Overview
Table 77. Chengdu Beite Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Chengdu Beite Pharmaceutical Co., Ltd. Cardiac Glycosides Product
Table 79. Chengdu Beite Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 80. Southwest Pharmaceutical Co., Ltd. Company Information
Table 81. Southwest Pharmaceutical Co., Ltd. Description and Business Overview
Table 82. Southwest Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Southwest Pharmaceutical Co., Ltd. Cardiac Glycosides Product
Table 84. Southwest Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 85. Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Company Information
Table 86. Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Description and Business Overview
Table 87. Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Cardiac Glycosides Product
Table 89. Shanghai Shanghai Pharmaceuticals Xinyi Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 90. Chengdu Haitong Pharmaceutical Co., Ltd. Company Information
Table 91. Chengdu Haitong Pharmaceutical Co., Ltd. Description and Business Overview
Table 92. Chengdu Haitong Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Chengdu Haitong Pharmaceutical Co., Ltd. Cardiac Glycosides Product
Table 94. Chengdu Haitong Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 95. Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Company Information
Table 96. Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Description and Business Overview
Table 97. Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Cardiac Glycosides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Cardiac Glycosides Product
Table 99. Harbin Pharmaceutical Group Pharmaceutical Factory No. 6 Recent Developments/Updates
Table 100. China Resources Double Crane Pharmaceutical Co., Ltd. Company Information
Table 101. China Resources Double Crane Pharmaceutical Co., Ltd. Description and Business Overview
Table 102. China Resources Double Crane Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. China Resources Double Crane Pharmaceutical Co., Ltd. Cardiac Glycosides Product
Table 104. China Resources Double Crane Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 105. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Company Information
Table 106. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Description and Business Overview
Table 107. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Cardiac Glycosides Product
Table 109. Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 110. Shandong Weizhi Baike Pharmaceutical Co., Ltd. Company Information
Table 111. Shandong Weizhi Baike Pharmaceutical Co., Ltd. Description and Business Overview
Table 112. Shandong Weizhi Baike Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Shandong Weizhi Baike Pharmaceutical Co., Ltd. Cardiac Glycosides Product
Table 114. Shandong Weizhi Baike Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 115. Shanghai Zhaohui Pharmaceutical Co., Ltd. Company Information
Table 116. Shanghai Zhaohui Pharmaceutical Co., Ltd. Description and Business Overview
Table 117. Shanghai Zhaohui Pharmaceutical Co., Ltd. Cardiac Glycosides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Shanghai Zhaohui Pharmaceutical Co., Ltd. Cardiac Glycosides Product
Table 119. Shanghai Zhaohui Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Cardiac Glycosides Distributors List
Table 123. Cardiac Glycosides Customers List
Table 124. Cardiac Glycosides Market Trends
Table 125. Cardiac Glycosides Market Drivers
Table 126. Cardiac Glycosides Market Challenges
Table 127. Cardiac Glycosides Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cardiac Glycosides
Figure 2. Global Cardiac Glycosides Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Cardiac Glycosides Market Share by Type: 2023 & 2030
Figure 4. Digoxin Product Picture
Figure 5. Scutellarin K Product Picture
Figure 6. Deacetylated Scutellarin Product Picture
Figure 7. Global Cardiac Glycosides Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Cardiac Glycosides Market Share by Application: 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Other
Figure 12. Global Cardiac Glycosides Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Cardiac Glycosides Market Size (2019-2030) & (US$ Million)
Figure 14. Global Cardiac Glycosides Sales (2019-2030) & (K Units)
Figure 15. Global Cardiac Glycosides Average Price (US$/Unit) & (2019-2030)
Figure 16. Cardiac Glycosides Report Years Considered
Figure 17. Cardiac Glycosides Sales Share by Manufacturers in 2023
Figure 18. Global Cardiac Glycosides Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Cardiac Glycosides Players: Market Share by Revenue in Cardiac Glycosides in 2023
Figure 20. Cardiac Glycosides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Cardiac Glycosides Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Cardiac Glycosides Sales Market Share by Country (2019-2030)
Figure 23. North America Cardiac Glycosides Revenue Market Share by Country (2019-2030)
Figure 24. United States Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Cardiac Glycosides Sales Market Share by Country (2019-2030)
Figure 27. Europe Cardiac Glycosides Revenue Market Share by Country (2019-2030)
Figure 28. Germany Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Cardiac Glycosides Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Cardiac Glycosides Revenue Market Share by Region (2019-2030)
Figure 35. China Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Cardiac Glycosides Sales Market Share by Country (2019-2030)
Figure 43. Mexico Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Cardiac Glycosides Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Cardiac Glycosides Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Cardiac Glycosides Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Cardiac Glycosides by Type (2019-2030)
Figure 53. Global Revenue Market Share of Cardiac Glycosides by Type (2019-2030)
Figure 54. Global Cardiac Glycosides Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Cardiac Glycosides by Application (2019-2030)
Figure 56. Global Revenue Market Share of Cardiac Glycosides by Application (2019-2030)
Figure 57. Global Cardiac Glycosides Price (US$/Unit) by Application (2019-2030)
Figure 58. Cardiac Glycosides Value Chain
Figure 59. Cardiac Glycosides Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
